The article compares the guidelines of the National Comprehensive Cancer Network (NCCN) for treatment of prostate cancer with those of the American Urological Association (AUA) in 2010. The NCCN guidelines were aimed at helping urologists in caring for patients with this condition based on different...
They are widely used for preoperative staging and post-treatment recurrence monitoring. In this study, for visual analysis, the sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of using miPSMA scoring to diagnose prostate cancer in patients with PI-RADS 3/...
but which of these risk factors cause a prostate cell to become cancerous is not fully known. For a cancer to develop, changes must occur in the chemicals that make up the DNA, which makes up the genes in the cell. The genes control how the cell ...
but which of these risk factors cause a prostate cell to become cancerous is not fully known. For a cancer to develop, changes must occur in the chemicals that make up the DNA, which makes up the genes in the cell. The genes control how the cell ...
--A national, multidisciplinary practice guideline was developed concerning diagnosis and treatment of patients with prostate cancer. Because of the lack of sufficient scientific evidence at this moment no practice guideline on screening is included. --The diagnosis of prostate cancer is made by trans...
Prostate Cancer: Diagnosis and Treatment (Supplement) As part of the Prostate Cancer guideline development process the National Collaborating Centre for Cancer (NCC-C) invited the National South West Public He... T Cross,S Mcphail - National Collaborating Centre for Cancer (UK) 被引量: 97发表...
an often-ignored facet in standard nccn guideline treatments. the majority of the patients following theseone-size-fits-all protocols do not get access to genomic testing, which is a part of precision oncology. at envita, every patient's entire treatment plan is based on our detailed precision...
Management of Prostate Cancer: EAU Guidelines on Screening, Diagnosis and Local Primary Treatment The 2016 EAU-ESTRO-SIOG Prostate cancer guideline is based on systematic revues and follows a strict methodology. The main change regarding pathology is the 2014 ISUP grading system in five grades, on...
Now, we are looking at the recent [National Comprehensive Cancer Network] guideline changes. Everyone should be undergoing [a prostate-specific membrane antigen (PSMA)] scan with basically intermediate-risk disease. I think that's kind of the first step in the process. All this is assuming ...
CLINICAL GUIDELINE: PART III: Screening for Prostate Cancer Prostate cancer, which caused an estimated 40 000 deaths and substantial aggregate illness in 1995, is now the most commonly diagnosed type of cancer among men in the United States [1]. However, whether early detection of this disease...